Stock Detail
PRESSURE BIOSCIENCES INC
Diagnostic Substances
PBIO @ Yahoo Finance | PBIO Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $0.75 | $0.79 | $0.04 | 5.63% | 0.00 | $0.71 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $0.79 | $0.70 | 36,150 | 2.2M | 7,382 | -0.89 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 0.84 | 0.80 | 0.75 | 0.71 | 0.66 |
Stock Profile
Pressure BioSciences, Inc. (PBI), an early-stage company, focuses on the development of a technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between various levels to control bio-molecular interactions. The company, utilizing its PCT technology, researches, develops, and commercializes products for the control of bio-molecular interactions. Its products primarily include Barocycler NEP 2017, an instrument that is designed as a front-end sample preparation tool for genomic and proteomic systems; Barocycler NEP 3229, which is a lightweight, portable instrument designed to fit on a laboratory bench top, inside a biological safety cabinet, or on the shelf of a cold room; and PULSE tubes that transmit the power of PCT from the Barocycler instruments to the sample. PBI holds 13 US and 4 foreign patents covering multiple applications of PCT in the life sciences field, including areas, such as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification. It also owns a 30% investment in Source Scientific, LLC, which is an instrumentation company that develops and manufactures PBI's PCT equipment. In addition, the company owns a passive investment in V.I. Technologies, Inc., formerly Panacos Pharmaceuticals, Inc., which is an antiviral drug discovery and development company. Pressure BioSciences was founded by Richard T. Schumacher in 1978. The company was formerly known as Boston Biomedica, Inc. (BBI) and changed its name to Pressure BioSciences, Inc. in September 2004, following the sale of assets and selected liabilities of its BBI Diagnostics and BBI Biotech divisions to SeraCare Life Sciences, Inc. Pressure BioSciences is headquartered in West Bridgewater, Massachusetts.